Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution.
about
Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignanciesChemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapySurgical technology and pharmacology of hyperthermic perioperative chemotherapyHemophagocytic syndrome: an unusual and underestimated complication of cytoreduction surgery with heated intraperitoneal oxaliplatin.Population pharmacokinetics of peritoneal, plasma ultrafiltrated and protein-bound oxaliplatin concentrations in patients with disseminated peritoneal cancer after intraperitoneal hyperthermic chemoperfusion of oxaliplatin following cytoreductive suHyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis.Platelet Dynamics in Peritoneal Carcinomatosis Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal OxaliplatinClosed hyperthermic intraperitoneal chemotherapy with open abdomen: a novel technique to reduce exposure of the surgical team to chemotherapy drugsProspective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases.Is Platinum Present in Blood and Urine from Treatment Givers during Hyperthermic Intraperitoneal Chemotherapy?Hyperthermic intraperitoneal chemotherapy: Rationale and techniqueOxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis.Pharmacokinetic and pharmacodynamic analysis of hyperthermic intraperitoneal oxaliplatin-induced neutropenia in subjects with peritoneal carcinomatosisA prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trialBody surface area predicts plasma oxaliplatin and pharmacokinetic advantage in hyperthermic intraoperative intraperitoneal chemotherapy.Activity ex vivo of cytotoxic drugs in patient samples of peritoneal carcinomatosis with special focus on colorectal cancer.Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasmsDevelopment of regional chemotherapies: feasibility, safety and efficacy in clinical use and preclinical studies.Rationale and techniques of cytoreductive surgery and peritoneal chemohyperthermia.Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review.Pharmacokinetics of the perioperative use of cancer chemotherapy in peritoneal surface malignancy patientsSplenectomy ameliorates hematologic toxicity of hyperthermic intraperitoneal chemotherapy.Splenectomy revisited in 2011: Impact on hematologic toxicities while performing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Complications of Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal MetastasesHyperthermic Intraperitoneal Chemotherapy (HIPEC) Methodology, Drugs and Bidirectional ChemotherapyCytoreductive Surgery plus HIPEC for Peritoneal Metastases from Colorectal CancerA phase I trial of oxaliplatin for intraperitoneal hyperthermic chemoperfusion for the treatment of peritoneal surface dissemination from colorectal and appendiceal cancers.Surgical cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis arising from the appendix.Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapyA comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C.Are there intra-operative hemodynamic differences between the Coliseum and closed HIPEC techniques in the treatment of peritoneal metastasis? A retrospective cohort study.Management of peritoneal carcinomatosis from colorectal cancer.Surgery for colorectal peritoneal carcinomatosis.Summary of current therapeutic options for peritoneal metastases from colorectal cancer.Hepatic necrosis and hemorrhage following hyperthermic intraperitoneal chemotherapy with oxaliplatin: A review of two cases.Cytoreductive surgery and intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis from colorectal origin.Intraperitoneal chemotherapy: rationale, applications, and limitations.Drug development for intraperitoneal chemotherapy against peritoneal carcinomatosis from gastrointestinal cancer.Peritoneal cancer treatment.
P2860
Q26738517-C8F61591-406D-440F-8C99-4C717D860F33Q26768402-91F8D04A-F5E9-4233-AAF5-5B21FCFB41E8Q26768405-B9897756-F60A-4BFC-8060-2562B21906DBQ33408999-6BE550D7-C85C-4D9B-850E-BD05142BC65AQ33416659-95DD4397-C346-4FCB-BEB6-C0D6580E967CQ33418610-0416D51A-F27D-4FF3-8986-4C1D52AD4C17Q33427607-879F2247-8219-40C1-8D2C-66975E416FE8Q33920966-A9DFCF92-29CE-47BB-AC1B-FC3079955187Q33931049-CB476B8E-ECAA-4DD4-B3E3-4681F7BA4A2BQ33988091-F5033AAA-60A0-4410-8289-170A1125520FQ34391107-7C7973CE-C75D-45DC-AA18-3447D4F1BC25Q34491336-F3796BEF-642C-4AC8-B6FA-B691250DCFF0Q34544598-8B37AB7D-0504-440B-BA95-DDF05BA51F46Q34580450-E0BA2A99-5AA7-4768-872A-975B6F315C61Q34605976-32ACBF6A-2F49-4E60-8057-9600B2406A0FQ34996489-7D91A2CE-9A5C-48E1-8DD7-BCF43CA9B6ADQ35445073-460F7AA1-61FB-4D64-9B51-1D5433D88522Q35646297-3A2D2C39-BA0E-499D-9038-A6556DEC91D9Q35653290-4FBAAEE3-FD4A-4952-83D5-71CEF0D104B3Q35678364-C960BA15-2E18-479D-A435-AAE193CC73A5Q36063487-8394D3B7-D0A3-4E5A-B213-7BAD9C92864BQ36097154-B73E2C8A-98CB-4A9A-BAD8-41214E275A01Q36097165-D2C32654-5C29-4E1D-9D2D-FF7346053429Q36758917-26D6F6F4-E413-4BCC-A474-89B33237A000Q36758933-FF666355-BC6B-46AB-A1BB-37CC489BA750Q36758936-8520638C-CB4C-4213-BA91-1C117A3927C6Q36989557-1A8904BB-F60E-45C8-B62E-86D33B4EB8B6Q37145798-2E1FE2FA-24C4-4470-AA4B-4AFAA9E2B7EFQ37260591-AE13D736-C84B-4A81-8D13-CB889182B53CQ37291528-39504FA3-AAFE-406E-9350-0F2525845886Q37597149-DA145BB5-C3B7-41BA-A700-5B65A2B6A207Q37658352-392FBC96-50A0-405E-A319-13F4A180EEB0Q37910396-1DDD870E-56BB-44C1-8A28-1855CF613019Q37977476-3D3B42D5-7D52-4662-837F-DE04C8050502Q38017942-E290662F-9D8D-4AC7-9F5C-18382F76F161Q38027521-4066E01D-D8DF-4C83-8F71-7E52401C1C31Q38112342-CBAB1A8B-6CFC-46AE-B4BA-1B69D6A35873Q38156120-D7BC461F-CB20-49AD-B24E-0EA31946B10DQ38183786-3879B802-09F4-47A1-8760-B5A67D3D6C98Q38195114-36B5BDEF-7347-4D88-ACA1-911DF6D89EDC
P2860
Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Heated intra-operative intrape ...... etics and tissue distribution.
@en
Heated intra-operative intrape ...... etics and tissue distribution.
@nl
type
label
Heated intra-operative intrape ...... etics and tissue distribution.
@en
Heated intra-operative intrape ...... etics and tissue distribution.
@nl
prefLabel
Heated intra-operative intrape ...... etics and tissue distribution.
@en
Heated intra-operative intrape ...... etics and tissue distribution.
@nl
P2093
P2860
P356
P1433
P1476
Heated intra-operative intrape ...... etics and tissue distribution.
@en
P2093
J F Ouellet
J M Puizillou
J P Pignon
L Drouard-Troalen
Otmany A El
S Demirdjian
P2860
P304
P356
10.1093/ANNONC/MDF019
P577
2002-02-01T00:00:00Z